Search This Blog

Tuesday, April 4, 2023

Lannett: Trial, Restructuring Updates

 Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product

Productive Conversations with Key Secured Creditors Toward a Balance Sheet Strengthening, Recapitalization or Restructuring Transaction Ongoing As Company Enters Grace Period for Failure to Pay Interest on Convertible Notes

https://finance.yahoo.com/news/lannett-shares-105500807.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.